Toggle Main Menu Toggle Search

ePrints

Browsing publications by Dr Mary Slatter

Newcastle AuthorsTitleYearFull text
Dr Katherine Sturgess
Dr Rachel Dickinson
Dr Andrew Gennery
Professor Andrew Cant
Professor Graham Jackson
et al.
In vivo T-depleted reduced intensity transplantation for GATA2-related immune dysfunction.2018
Dr Tom Altmann
Dr James Slack
Dr Mary Slatter
Professor Andrew Cant
Dr Matthew Thomas
et al.
Endothelial cell damage in idiopathic pneumonia syndrome2018
Dr Mary Slatter
Dr Andrew Gennery
Hematopoietic cell transplantation in primary immunodeficiency–conventional and emerging indications2018
Dr Mario Abinun
Dr Desa Lilic
Dr Andrew Gennery
Dr Mary Slatter
Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations2018
Dr Zohreh Nademi
Dr Mary Slatter
Dr Andrew Gennery
Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study2018
Dr Zohreh Nademi
Professor Andrew Cant
Professor Roderick Skinner
Dr Intan Abd Hamid
Dr Terence Flood
et al.
T-cell receptor αβ+ and CD19+ cell-depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency2018
Dr Aisling Flinn
Dr Mary Slatter
Professor Roderick Skinner
Dr Andrew Gennery
Thymopoiesis following HSCT; a retrospective review comparing interventions for aGVHD in a pediatric cohort2018
Dr Mary Slatter
Dr Intan Abd Hamid
Dr Zohreh Nademi
Professor Mark Pearce
Dr Terence Flood
et al.
Treosulfan and Fludarabine Conditioning for Hematopoietic Stem Cell Transplantation in Children with Primary Immunodeficiency: UK Experience2018
Dr Mary Slatter
Dr Andrew Gennery
Approaches to the removal of T-lymphocytes to minimize graft-versus-host disease in patients with primary immunodeficiencies who do not have a matched sibling donor2017
Dr Andrew Gennery
Dr Mary Slatter
Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT2017
12345678910111213